Sponsor Pipeline

E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07180511 A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic… Atopic Dermatitis (AD) Enrolling by Invitation
Phase 2
NCT07712523 A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II… Adult Subjects With Non-Segmental Vitiligo Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free